The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
SWOG S0715: Randomized placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy during adjuvant breast cancer therapy.
Dawn L. Hershman
No relevant relationships to disclose
Joseph M Unger
No relevant relationships to disclose
Katherine D. Crew
No relevant relationships to disclose
Carol Moinpour
No relevant relationships to disclose
Lori M. Minasian
No relevant relationships to disclose
Lisa Hansen
No relevant relationships to disclose
Danika Lew
No relevant relationships to disclose
Patricia OKane
No relevant relationships to disclose
James Lloyd Wade
No relevant relationships to disclose
Siu-Fun Wong
No relevant relationships to disclose
Gabriel N. Hortobagyi
No relevant relationships to disclose
Frank L. Meyskens
No relevant relationships to disclose
Kathy S. Albain
No relevant relationships to disclose